Kim Brazzell
2021
In 2021, Kim Brazzell earned a total compensation of $1.3M as Head of Research and Development and Chief Medical Officer at Kala Pharmaceuticals.
Compensation breakdown
| Bonus | $150,005 |
|---|---|
| Option Awards | $483,131 |
| Salary | $476,207 |
| Stock Awards | $188,650 |
| Other | $18,976 |
| Total | $1,316,969 |
Brazzell received $483.1K in option awards, accounting for 37% of the total pay in 2021.
Brazzell also received $150K in bonus, $476.2K in salary, $188.7K in stock awards and $19K in other compensation.
Rankings
In 2021, Kim Brazzell's compensation ranked 7,772nd out of 12,405 executives tracked by ExecPay. In other words, Brazzell earned more than 37.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,772 out of 12,405 | 37th |
Division Manufacturing | 3,427 out of 5,494 | 38th |
Major group Chemicals And Allied Products | 1,520 out of 2,369 | 36th |
Industry group Drugs | 1,353 out of 2,090 | 35th |
Industry Pharmaceutical Preparations | 997 out of 1,537 | 35th |
Source: SEC filing on March 13, 2023.
Brazzell's colleagues
We found two more compensation records of executives who worked with Kim Brazzell at Kala Pharmaceuticals in 2021.